Retour

TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.

News Press releases

TAMPA, FL, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of a pharmaceutical business-to-business exchange platform, announced today that it received a notice of non-compliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) on November 21, 2023 notifying the Company that, as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”).

GlobeNewswire Inc. • 30/11/2023 à 00:13:00
TRxADE HEALTH, Inc. Common Stock
Adresse: 2420 BRUNELLO TRACE
Code postal: 33558
Ville: LUTZ
Region: FL
Numéro de telephone: (800) 261 0281
Site internet: https://www.trxadehealth.com
Status: Active
Info de l'entreprise

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Date de référencement2008-02-22
MarchéStocks
LocaleUS
Echange principalXNAS
TypeCS
DeviseUSD
CIK0001382574
Composite figiBBG000RNLYM7
Share Class figiBBG001STZBS0
Market Cap12,670,442 USD
SIC Code5122
SIC DescriptionWHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Total Employés8
Share Class Shares Outstanding1750000
Weighted Shares Outstanding1750061
Round Lot100
Date de mise à jour2024-09-19
Stats
5 derniers jours
19-09
18-09
17-09
16-09
13-09
Dernier
7.23
7.099
7.006
7.086
7.08
Variation
1.62%
1.34%
-1.12%
-0.08%
3.48%
Ouverture
7.115
7.005
7.085
7.092
6.842
Plus haut
7.24
7.2
7.46
7.325
7.419
Plus bas
7.23
7.2
7.46
7.325
7.291
Historique
PériodeVarPlus hautPlus bas
1 semaine
7.21%
7.419
7.2
1 mois
-17.98%
9.01
6.95
3 mois
-20.44%
9.61
6.735
6 mois
-61.15%
21.3077
5.3
1 an
-2.2%
7.72
3.69
3 ans
-90.3%
76.05
3.69
5 ans
-91.71%
120
3.69
10 ans
-91.71%
120
3.69
Bilans
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-18 UNPUB UNPUB
Assets 4,037,771 3,744,985 UNPUB UNPUB
Current Assets 2,386,113 2,095,045 UNPUB UNPUB
Current Liabilities 2,550,148 4,262,947 UNPUB UNPUB
Equity 655,140 -1,294,527 UNPUB UNPUB
Equity Attributable To Noncontrolling Interest 0 0 UNPUB UNPUB
Equity Attributable To Parent 655,140 -1,294,527 UNPUB UNPUB
Liabilities 3,382,631 5,039,512 UNPUB UNPUB
Liabilities And Equity 4,037,771 3,744,985 UNPUB UNPUB
Noncurrent Assets 1,651,658 1,649,940 UNPUB UNPUB
Noncurrent Liabilities 832,483 776,565 UNPUB UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-18 UNPUB UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 82,923 -448,518 UNPUB UNPUB
Net Cash Flow, Continuing -305,713 -448,518 UNPUB UNPUB
Net Cash Flow From Financing Activities 681,257 -725,281 UNPUB UNPUB
Net Cash Flow From Financing Activities, Continuing 681,257 -725,281 UNPUB UNPUB
Net Cash Flow From Investing Activities 333,197 -51,803 UNPUB UNPUB
Net Cash Flow From Investing Activities, Continuing -87,072 -51,803 UNPUB UNPUB
Net Cash Flow From Operating Activities -931,531 328,566 UNPUB UNPUB
Net Cash Flow From Operating Activities, Continuing -899,898 328,566 UNPUB UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-18 UNPUB UNPUB
Comprehensive Income/Loss -677,953 -1,974,878 UNPUB UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 UNPUB UNPUB
Comprehensive Income/Loss Attributable To Parent -677,953 -1,974,878 UNPUB UNPUB
Other Comprehensive Income/Loss 0 0 UNPUB UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-18 UNPUB UNPUB
Basic Earnings Per Share 0 -3 UNPUB UNPUB
Benefits Costs and Expenses 2,573,459 4,225,954 UNPUB UNPUB
Cost Of Revenue 690,670 606,349 UNPUB UNPUB
Costs And Expenses 2,573,459 4,225,954 UNPUB UNPUB
Diluted Earnings Per Share UNPUB -3 UNPUB UNPUB
Gross Profit 1,557,080 1,644,727 UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -325,709 -1,974,878 UNPUB UNPUB
Income/Loss From Continuing Operations Before Tax -325,709 -1,974,878 UNPUB UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 62,392 180,734 UNPUB UNPUB
Net Income/Loss -677,953 -1,974,878 UNPUB UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 UNPUB UNPUB
Net Income/Loss Attributable To Parent -677,953 -1,974,878 UNPUB UNPUB
Net Income/Loss Available To Common Stockholders, Basic -677,953 -1,974,878 UNPUB UNPUB
Operating Expenses 1,904,486 1,990,352 UNPUB UNPUB
Operating Income/Loss -347,406 -345,625 UNPUB UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 UNPUB UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 UNPUB UNPUB
Revenues 2,247,750 2,251,076 UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-07-25 2022-11-07 2023-03-27
Assets 5,840,211 5,672,460 4,689,261 3,710,026
Current Assets 3,597,067 3,347,378 2,373,006 2,093,123
Current Liabilities 1,596,333 2,546,409 2,061,352 2,146,791
Equity 2,887,578 1,804,533 1,356,578 342,867
Equity Attributable To Noncontrolling Interest 0 0 -42,426 -420,269
Equity Attributable To Parent 2,870,078 1,821,220 1,399,004 763,136
Liabilities 2,952,633 3,867,927 3,332,683 3,367,159
Liabilities And Equity 5,840,211 5,672,460 4,689,261 3,710,026
Noncurrent Assets 2,243,144 2,325,082 2,316,255 1,616,903
Noncurrent Liabilities 0 0 1,271,331 1,220,368
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-07-25 2022-11-07 2023-03-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,000,771 1,000,771 0 -1,988,945
Net Cash Flow, Continuing -1,000,771 1,000,771 0 -1,988,945
Net Cash Flow From Financing Activities UNPUB UNPUB -7,857 -35,171
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -7,857 -35,171
Net Cash Flow From Investing Activities UNPUB UNPUB 584,782 -427,845
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 584,782 -427,845
Net Cash Flow From Operating Activities -1,000,771 -1,178,283 -576,925 -1,525,929
Net Cash Flow From Operating Activities, Continuing -1,000,771 -1,178,283 -576,925 -1,525,929
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-07-25 2022-11-07 2023-03-27
Comprehensive Income/Loss -965,836 -1,112,261 -528,742 -3,909,868
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -965,836 -1,112,261 -528,742 -3,909,868
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-07-25 2022-11-07 2023-03-27
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 4,206,108 4,390,990 2,929,053 15,358,133
Cost Of Revenue 1,904,569 2,107,815 998,320 5,997,049
Costs And Expenses 4,206,108 4,390,990 2,929,053 15,358,133
Diluted Earnings Per Share 0 0 0 0
Gross Profit 1,335,703 1,170,914 1,401,991 5,451,216
Income/Loss From Continuing Operations After Tax -965,836 -1,112,261 -528,742 -3,909,868
Income/Loss From Continuing Operations Before Tax -965,836 -1,112,261 -528,742 -3,909,868
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 1,364 9,155 130,107 336,206
Net Income/Loss -965,836 -1,112,261 -528,742 -3,909,868
Net Income/Loss Attributable To Noncontrolling Interest 0 0 -25,739 -437,769
Net Income/Loss Attributable To Parent -960,147 -1,083,763 -503,003 -3,472,099
Net Income/Loss Available To Common Stockholders, Basic -960,147 -1,083,763 -503,003 -3,472,099
Operating Expenses 2,304,275 2,274,020 1,809,022 9,875,511
Operating Income/Loss -968,572 -1,103,106 -407,031 -4,424,295
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 3,240,272 3,278,729 2,400,311 11,448,265
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-26 2021-07-26 2021-10-25 2022-03-28
Assets 9,693,216 6,896,030 5,514,101 5,766,164
Current Assets 9,155,240 6,536,167 5,189,274 4,374,244
Current Liabilities 1,237,680 861,051 654,861 926,026
Equity 8,201,624 5,786,977 4,617,295 3,770,173
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 8,201,624 5,786,977 4,617,295 3,770,173
Liabilities 1,491,592 1,109,053 896,806 1,995,991
Liabilities And Equity 9,693,216 6,896,030 5,514,101 5,766,164
Noncurrent Assets 537,976 359,863 324,827 1,391,920
Noncurrent Liabilities 0 0 241,945 1,069,965
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-26 2021-07-26 2021-10-25 2022-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -710,298 710,298 0 -2,797,000
Net Cash Flow, Continuing -710,298 710,298 0 -2,797,000
Net Cash Flow From Financing Activities UNPUB UNPUB -209,999 -208,178
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -209,999 -208,178
Net Cash Flow From Investing Activities UNPUB UNPUB 948,094 -22,596
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 948,094 -22,596
Net Cash Flow From Operating Activities -710,298 -691,118 -738,095 -2,566,226
Net Cash Flow From Operating Activities, Continuing -710,298 -691,118 -738,095 -2,566,226
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-26 2021-07-26 2021-10-25 2022-03-28
Comprehensive Income/Loss -651,519 -2,578,276 -1,301,748 -5,315,883
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -651,519 -2,578,276 -1,301,748 -5,315,883
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-04-26 2021-07-26 2021-10-25 2022-03-28
Basic Earnings Per Share 0 UNPUB UNPUB UNPUB
Benefits Costs and Expenses 3,704,754 0 0 15,205,316
Cost Of Revenue 1,669,924 1,056,863 1,269,005 5,143,468
Costs And Expenses 3,704,754 4,467,842 3,846,172 15,205,316
Diluted Earnings Per Share 0 UNPUB UNPUB UNPUB
Gross Profit 1,383,311 841,391 1,281,041 4,745,965
Income/Loss From Continuing Operations After Tax -651,519 -2,578,276 -1,301,748 -5,315,883
Income/Loss From Continuing Operations Before Tax -651,519 -2,578,276 2,550,046 -5,315,883
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 7,264 8,688 5,622 23,590
Net Income/Loss -651,519 -2,578,276 -1,301,748 -5,315,883
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -651,519 -2,578,276 -1,301,748 -5,315,883
Net Income/Loss Available To Common Stockholders, Basic -651,519 -2,578,276 -1,301,748 -5,315,883
Operating Expenses 2,027,566 3,410,979 2,577,167 10,038,258
Operating Income/Loss -644,255 -2,569,588 -1,296,126 -5,292,293
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 3,053,235 1,898,254 2,550,046 9,889,433
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-07-27 2020-10-26 2021-03-29
Assets 11,473,904 11,732,283 11,854,010 9,792,702
Current Assets 9,794,978 10,123,366 10,643,254 9,221,298
Current Liabilities 950,529 719,825 534,897 842,238
Equity 9,637,297 10,151,377 10,827,089 8,679,158
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 9,637,297 10,151,377 10,827,089 8,679,158
Liabilities 1,836,607 1,580,906 1,026,921 1,113,544
Liabilities And Equity 11,473,904 11,732,283 11,854,010 9,792,702
Noncurrent Assets 1,678,926 1,608,917 1,210,756 571,404
Noncurrent Liabilities 0 0 492,024 271,306
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-07-27 2020-10-26 2021-03-29
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 4,829,611 -3,550,261 2,496,719 3,047,884
Net Cash Flow, Continuing 4,829,611 -3,550,261 2,496,719 3,047,884
Net Cash Flow From Financing Activities 5,263,922 21,600 13,303 5,300,175
Net Cash Flow From Financing Activities, Continuing 5,263,922 21,600 13,303 5,300,175
Net Cash Flow From Investing Activities -23,505 0 0 -37,505
Net Cash Flow From Investing Activities, Continuing -23,505 0 0 -37,505
Net Cash Flow From Operating Activities -410,806 -3,571,861 2,483,416 -2,214,786
Net Cash Flow From Operating Activities, Continuing -410,806 -3,571,861 2,483,416 -2,214,786
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-07-27 2020-10-26 2021-03-29
Comprehensive Income/Loss 180,303 -542,587 138,391 -2,536,051
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 180,303 -542,587 138,391 -2,536,051
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-07-27 2020-10-26 2021-03-29
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 2,023,017 0 0 19,658,571
Cost Of Revenue 563,184 4,587,865 4,402,967 11,415,198
Costs And Expenses 2,023,017 7,127,914 6,186,448 19,658,571
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 1,640,136 2,004,772 1,929,302 5,707,322
Income/Loss From Continuing Operations After Tax 180,303 -542,587 138,391 -2,536,051
Income/Loss From Continuing Operations Before Tax 180,303 -542,587 6,332,269 -2,536,051
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 7,924 7,310 7,430 29,389
Net Income/Loss 180,303 -542,587 138,391 -2,536,051
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 180,303 -542,587 138,391 -2,536,051
Net Income/Loss Available To Common Stockholders, Basic 180,303 -542,587 138,391 -2,536,051
Operating Expenses 1,451,909 2,540,049 1,783,481 8,213,984
Operating Income/Loss 188,227 -535,277 145,821 -2,506,662
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 2,203,320 6,592,637 6,332,269 17,122,520
Calendrier économique
20 Septembre 2024 (heure UTC) Actuel Précédent Consensus
★
15:30
United States
SEP 17
3200.000
2400.000
★
15:30
United States
SEP 17
19700.000
12800.000
★
15:30
United States
SEP 17
-66300.000
-47800.000
★
15:30
United States
SEP 17
145300.000
140000.000
★
15:30
United States
★
15:30
United States
SEP 17
310100.000
282500.000
★
15:30
United States
★★
15:30
United States
SEP 17
19200.000
25600.000
★★
15:30
United States
★
15:30
United States
SEP 17
-89600.000
-87600.000
★
15:30
United States
SEP 17
-122900.000
-59400.000
★
15:30
United States
★
15:30
United States
SEP 17
58300.000
44700.000
★
15:30
United States
SEP 17
-134600.000
-144200.000
★
15:30
United States
SEP 17
-14200.000
-16300.000
Flux d'actualités
News TRxADE Health
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TRxADE Health, Inc. is changing its name to Scienture Holdings, Inc. and its stock will trade under the new ticker symbol SCNX. Scienture, LLC, a wholly-owned subsidiary, is a branded specialty pharmaceutical company that recently merged with TRxADE Health.
GlobeNewswire Inc. • Il y a 4 heures
News Press releases
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
GlobeNewswire Inc. • Il y a 3 mois
News Press releases
TRxADE Health, Inc. Announces Special Cash Dividend
TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.
GlobeNewswire Inc. • Il y a 6 mois
News Press releases
Trxade health, Inc files its 3Q 10Q
TAMPA, FL, Jan. 17, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”).
GlobeNewswire Inc. • Il y a 8 mois
News Press releases
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.
TAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc. (“Superlatus”), today reconfirms its commitment to pharmaceutical marketplace via its subsidiary Trxade, Inc. and is pleased to clarify its commitment to the pharmaceutical industry. Trxade, Inc., a subsidiary of Trxade Health, Inc. (the “Company”), will continue to focus on the pharmaceutical space. The Company is dedicated to serving the pharmaceutical industry and its over 13,000 members, reinforcing its position as a key player in this critical sector, adding 199 new members to its marketplace in the third quarter of 2023.
GlobeNewswire Inc. • Il y a 11 mois
News Press releases
Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales
TAMPA, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a food technology and distribution company and wholly owned subsidiary of TRxADE HEALTH, Inc. (NASDAQ: MEDS, “TRxADE”), a pharmaceutical exchange platform provider, is pleased to announce that its subsidiary, Superlatus PD Holding Company, has entered into a supplier agreement with Rainforest Distribution Corp. (“Rainforest”), a leading Consumer Packaged Goods distributor serving over 3,000 retailers across 15 states in the Mid-Atlantic, Midwest, Northeast and North Atlantic regions of the United States.
GlobeNewswire Inc. • Il y a 11 mois
News Press releases
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.
TAMPA, FL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), wholly owned subsidary of TRxADE HEALTH, Inc. (NASDAQ: MEDS), a pharmaceutical exchange platform provider, entered into an all-cash asset purchase agreement to acquire the assets of Spero Foods, Inc. (“Spero”) on October 2, 2023.
GlobeNewswire Inc. • Il y a 11 mois
stocks Press releases
Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The Company has unveiled its intent to introduce pulse-based twisted protein snacks through its Brave Robot brand. This disruptive innovation leverages the advanced food extrusion technology from Sapientia Technology, LLC ('Sapientia'), a wholly-owned subsidiary of the Company.
GlobeNewswire Inc. • Il y a 1 année
News Press releases
Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The Company has unveiled its intent to introduce pulse-based twisted protein snacks through its Brave Robot brand. This disruptive innovation leverages the advanced food extrusion technology from Sapientia Technology, LLC ('Sapientia'), a wholly-owned subsidiary of the Company.
GlobeNewswire Inc. • Il y a 1 année
stocks Press releases
Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
TAMPA, FL, Aug. 22, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS), a pharmaceutical exchange platform provider that recently merged with food technology and distribution company Superlatus, Inc., today entered into a binding agreement to acquire The Urgent Company, Inc. and its Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. consumer brands from Perfect Day, Inc.
GlobeNewswire Inc. • Il y a 1 année
Voir tous
Actualités liées
Dernières actualités

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT